2023
Retaining Patients with Drug-Resistant Tuberculosis on Treatment During the COVID-19 Pandemic — Dharavi, Mumbai, India, 2020–2022
Gomare M, Bhide S, Deshmukh R, Kaipilyawar S, Puri V, Moonan P, Khetade D, Nyendak M, Yeldandi V, Smith J, Tobias J, Date A, Joshi R, Kumar R, Ho C. Retaining Patients with Drug-Resistant Tuberculosis on Treatment During the COVID-19 Pandemic — Dharavi, Mumbai, India, 2020–2022. MMWR Morbidity And Mortality Weekly Report 2023, 72: 304-308. PMID: 36952291, PMCID: PMC10042620, DOI: 10.15585/mmwr.mm7212a2.Peer-Reviewed Original ResearchIsolation and Quarantine for Coronavirus Disease 2019 in the United States, 2020–2022
Oeltmann J, Vohra D, Matulewicz H, DeLuca N, Smith J, Couzens C, Lash R, Harvey B, Boyette M, Edwards A, Talboy P, Dubose O, Regan P, Loosier P, Caruso E, Katz D, Taylor M, Moonan P. Isolation and Quarantine for Coronavirus Disease 2019 in the United States, 2020–2022. Clinical Infectious Diseases 2023, 77: 212-219. PMID: 36947142, PMCID: PMC11094624, DOI: 10.1093/cid/ciad163.Peer-Reviewed Original ResearchConceptsCoronavirus disease 2019Case patientsDisease 2019Positive severe acute respiratory syndrome coronavirus 2 test resultAdult case patientsCase investigationCOVID-19Public health programsPublic health workforceHealth programsHealth workforceContact tracingPatientsHealth officialsMost adultsAdultsDaysImpact of contactRepresentative sampleTotalMore adultsPanel SurveyQuarantine
2022
Tuberculosis attributed to transmission within healthcare facilities, Botswana—The Kopanyo Study
Smith JP, Modongo C, Moonan PK, Dima M, Matsiri O, Fane O, Click ES, Boyd R, Finlay A, Surie D, Tobias JL, Zetola NM, Oeltmann JE. Tuberculosis attributed to transmission within healthcare facilities, Botswana—The Kopanyo Study. Infection Control And Hospital Epidemiology 2022, 43: 1603-1609. PMID: 35382909, PMCID: PMC9535034, DOI: 10.1017/ice.2021.517.Peer-Reviewed Original ResearchConceptsElectronic medical recordsHealthcare facilitiesPopulation-based molecular epidemiologic studyMolecular epidemiologic studiesTB casesTB diagnosisTB transmissionTB epidemicMedical recordsTuberculosis diseaseBiologic plausibilityHealthcare workersIndividual patientsEpidemiologic studiesGeneral populationCommunity transmissionEtiologic agentTreatment dataClinical encountersPatientsEffective interventionsIndividual riskEMR dataTransmission eventsHigh-risk environments